XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
3.75% Convertible Senior Notes
Common Stock
5.5% Convertible Senior Notes
Common Stock
Private placement
Common Stock
Additional Paid-in-Capital
3.75% Convertible Senior Notes
Additional Paid-in-Capital
5.5% Convertible Senior Notes
Additional Paid-in-Capital
Private placement
Additional Paid-in-Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Accumulated Deficit
3.75% Convertible Senior Notes
5.5% Convertible Senior Notes
Private placement
Total
Balance at Dec. 31, 2019       $ 3,186       $ 1,506,953 $ 1,288 $ (31,216) $ (1,350,307)       $ 129,904
Balance (in shares) at Dec. 31, 2019       318,637,560           15,259,045          
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to the Company                     (596,155)       (596,155)
Other comprehensive (loss) gain                 1,163           1,163
Stock-based compensation       $ 4       17,131             17,135
Stock-based compensation (in shares)       439,649                      
Stock dividend               26     (26)        
Stock dividend (in shares)       5,156                      
Issuance of common stock, net       $ 790       1,270,872             1,271,662
Issuance of common stock, net (in shares)       78,976,250                      
Stock option exercises       $ 181       41,060   $ (9,218)         32,023
Stock option exercises (in shares)       18,056,200           667,023          
Equity component of 3.75% Convertible Senior Notes issued, net of issuance costs and income tax expense               100,761             100,761
Purchase of capped calls               (16,253)             (16,253)
Termination of capped calls               24,158             24,158
Exercise of warrants       $ 52       (52)              
Exercise of warrants (in shares)       5,180,457                      
Provision for common stock warrants               439,915             439,915
Accretion of discount, preferred stock               (29)             (29)
Conversion of preferred stock       $ 30       1,149             1,179
Conversion of preferred stock (in shares)       2,998,526                      
Conversion of 3.75% Convertible Senior Note       $ 306       62,247             62,553
Conversion of 3.75% Convertible Senior Note (in shares)       30,615,615                      
Repurchase of 5.5% Convertible Senior Notes, net of income tax benefit       $ 94       (50,864)             (50,770)
Repurchase of 5.5% Convertible Senior Notes, net of income tax benefit (in shares)       9,409,591                      
Common stock issued for acquisitions       $ 97       49,576             49,673
Common stock issued for acquisitions (in shares)       9,658,465                      
Balance at Dec. 31, 2020       $ 4,740       3,446,650 2,451 $ (40,434) (1,946,488)       $ 1,466,919
Balance (in shares) at Dec. 31, 2020       473,977,469           15,926,068          
Increase (Decrease) in Stockholders' Equity                              
Issuance of common stock, net (in shares)                             32,200,000
Balance at Dec. 31, 2020       $ 4,740       3,446,650 2,451 $ (40,434) (1,946,488)       $ 1,466,919
Balance (in shares) at Dec. 31, 2020       473,977,469           15,926,068          
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to the Company                     (459,965)       (459,965)
Other comprehensive (loss) gain                 (3,983)           (3,983)
Stock-based compensation       $ 1       76,469             76,470
Stock-based compensation (in shares)       100,662                      
Issuance of common stock, net     $ 549 $ 322     $ 1,564,065 2,022,897           $ 1,564,614 2,023,219
Issuance of common stock, net (in shares)     54,966,188 32,200,000                      
Stock option exercises       $ 51       7,469             7,520
Stock option exercises (in shares)       5,097,667                      
Stock exchanged for tax withholding                   $ (32,092)         (32,092)
Stock exchanged for tax withholding (in shares)                   1,148,642          
Exercise of warrants       $ 242       15,203             15,445
Exercise of warrants (in shares)       24,210,984                      
Provision for common stock warrants               6,142             6,142
Conversion of 3.75% Convertible Senior Note $ 30 $ 1     $ 15,155 $ 159           $ 15,185 $ 160    
Conversion of 3.75% Convertible Senior Note (in shares) 3,016,036 69,808                          
Common stock issued for acquisitions       $ 11       46,686             46,697
Common stock issued for acquisitions (in shares)       1,090,796                      
Balance (ASU 2020-06) at Dec. 31, 2021               (130,185)     9,550       (120,635)
Balance at Dec. 31, 2021       $ 5,947       7,070,710 (1,532) $ (72,526) (2,396,903)       $ 4,605,696
Balance (in shares) at Dec. 31, 2021       594,729,610           17,074,710         594,729,610
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to the Company                     (724,008)       $ (724,008)
Other comprehensive (loss) gain                 (24,472)           (24,472)
Issuance of common stock under restricted stock award       $ 51       (51)              
Issuance of common stock under restricted stock award (in shares)       5,148,459                      
Stock-based compensation       $ 6       179,621             179,627
Stock-based compensation (in shares)       584,545                      
Stock option exercises       $ 8       2,293             2,301
Stock option exercises (in shares)       757,424                      
Stock exchanged for tax withholding                   $ (23,735)         (23,735)
Stock exchanged for tax withholding (in shares)                   1,001,417          
Exercise of warrants       $ 68       (68)              
Exercise of warrants (in shares)       6,793,479                      
Provision for common stock warrants               38,698             38,698
Common stock issued for acquisitions       $ 4       6,103             6,107
Common stock issued for acquisitions (in shares)       408,268                      
Balance at Dec. 31, 2022       $ 6,084       $ 7,297,306 $ (26,004) $ (96,261) $ (3,120,911)       $ 4,060,214
Balance (in shares) at Dec. 31, 2022       608,421,785           18,076,127         608,421,785